SERES THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.825 USD | +11.08% |
|
+47.35% | -41.07% |
| 04-26 | Foreign automakers eager for Chinese partners at Beijing auto show | RE |
| 04-25 | Battle for 'tech luxury' in China as EVs get smarter - and cheaper | RE |
Chart calendar Seres Therapeutics, Inc.
a7d69b5060d9b.zGAi5V_KhddWJEPkJbrp9Z9DpTOt2uxEE-Ut-GrDKB8.hyl4j2f4vZgAXhuQcejQzfYR71KAvat9VLYelTCOclr4EmuXDrC1kmATLA~20e14e476176d9fe68aab40099c1a332
Upcoming events on Seres Therapeutics, Inc.
Past events on Seres Therapeutics, Inc.
| 04/04/2024 13:00 | Annual General Meeting |
| 06/03/2024 14:10 | TD Cowen Health Care Conference - Panel |
| 05/03/2024 13:30 | Q4 2023 Earnings Call |
| 05/03/2024 12:00 | Q4 2023 Earnings Release |
| 10/01/2024 17:45 | JPMorgan Healthcare Conference |
| 09/12/2023 22:30 | American Society of Hematology Meeting - Poster number: 2198 |
| 29/11/2023 20:30 | Piper Sandler Healthcare Conference |
| 02/11/2023 12:00 | Q3 2023 Earnings Call |
| 02/11/2023 11:00 | Q3 2023 Earnings Release |
| 12/10/2023 17:15 | IDWeek Conference - Abstract Number: 653 |
| 12/10/2023 17:15 | IDWeek Conference - Abstract Number: 655 |
| 11/09/2023 17:15 | Morgan Stanley Global Healthcare Conference |
| 09/08/2023 20:00 | Canaccord Genuity Growth Conference |
| 08/08/2023 13:30 | Q2 2023 Earnings Call |
| 08/08/2023 12:00 | Q2 2023 Earnings Release |
| 22/06/2023 13:00 | Annual General Meeting |
| 13/06/2023 00:40 | Goldman Sachs Global Healthcare Conference |
| 07/06/2023 13:00 | Jefferies Global Healthcare Conference |
| 09/05/2023 13:30 | Q1 2023 Earnings Call |
| 09/05/2023 12:00 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 34,5 33,1 4.14% | 33,2 22,6 47.01% | 145 150 -3.27% | 7,13 13,7 -48.15% | 126 126 0.18% | 1,16 |
|
EBITDA Million USD | Released Forecast Spread | -64,3 -74,0 13.09% | -81,6 -95,2 14.31% | -58,5 -51,5 -13.65% | -240 -238 -0.72% | -96,1 -117 18.1% | -142 |
|
EBIT Million USD | Released Forecast Spread | -71,9 -72,7 1.17% | -88,1 -95,6 7.79% | -64,5 -65,5 1.46% | -246 -232 -6.35% | -102 -123 16.49% | -171 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -70,3 -70,2 -0.12% | -89,1 -93,8 4.95% | -65,6 -57,7 -13.7% | -250 -231 -8.08% | -114 -124 7.96% | -185 |
|
Net income Million USD | Released Forecast Spread | -70,3 -70,1 -0.24% | -89,1 -95,7 6.87% | -65,6 -59,3 -10.53% | -250 -233 -7.22% | -114 -128 11.48% | -186 |
|
EPS USD | Released Forecast Spread | -1,24 -1,28 2.87% | -1,12 -1,10 -1.59% | -0,72 -0,62 -16.97% | -2,31 -2,16 -6.76% | -0,89 -0,99 9.81% | -1,14 |
| Announcement Date | 02/03/20 | 02/03/21 | 01/03/22 | 07/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,22 13,4 -46.28% | 1,49 9,52 -84.32% | 1,22 4,55 -73.26% | 3,44 7,01 -50.87% | 0,98 6,00 -83.76% | 1,58 | 126 126 0.64% | 0,31 0,85 -63.66% | 0,06 -0,18 135.39% | 0,25 | 0,25 | 0,25 | 0,25 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -49,4 -50,0 1.2% | -55,8 -49,3 -13.11% | -63,3 -54,3 -16.63% | -59,1 -55,2 -7.11% | -68,3 -55,5 -23.17% | -70,6 -70,6 0.03% | 49,5 68,8 -28% | -47,4 -62,0 23.49% | -33,9 -54,0 37.16% | -45,1 | -43,1 | -41,1 | -40,1 | -39,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,0 -41,7 -19.99% | -56,6 -51,6 -9.71% | -64,7 -53,9 -20.01% | -60,0 -51,9 -15.53% | -68,8 -53,1 -29.53% | -71,2 -72,0 1.16% | 46,6 69,7 -33.17% | -47,9 -59,7 19.85% | -41,2 -51,0 19.1% | -48,9 | -46,8 | -45,7 | -43,8 | -44,1 |
|
Net income Million USD | Released Forecast Spread | -50,0 -51,5 2.95% | -56,6 -48,8 -15.97% | -64,7 -54,8 -18.03% | -60,0 -54,3 -10.42% | -68,8 -54,5 -26.3% | -71,2 -71,0 -0.28% | 46,6 70,9 -34.3% | -47,9 -65,8 27.24% | -41,2 -55,9 26.16% | -48,9 | -46,8 | -45,7 | -43,8 | -44,1 |
|
EPS USD | Released Forecast Spread | -0,55 -0,44 -25.95% | -0,61 -0,52 -16.47% | -0,70 -0,60 -17.4% | -0,49 -0,47 -4.53% | -0,54 -0,46 -18.68% | -0,57 -0,55 -3.98% | 0,36 0,53 -32.64% | -0,37 -0,50 26.26% | -0,32 -0,50 35.66% | -0,34 | -0,31 | -0,27 | -0,27 | -0,29 |
| Announcement Date | 01/03/22 | 04/05/22 | 03/08/22 | 02/11/22 | 07/03/23 | 09/05/23 | 08/08/23 | 02/11/23 | 05/03/24 | - | - | - | - | - |
More events
Past sector events for Seres Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MCRB Stock
- Calendar Seres Therapeutics, Inc.
